Alpha-hydroxybutyrate dehydrogenase activity in intrahepatic cholestasis of pregnancy

J Wojcicka1, J Sienko, R Smolarczyk

  • 12nd Department of Obstetrics and Gynecology, Medical University of Warsaw, ul. Karowa 2, 00-315 Warsaw, Poland. jaceks@szpitalkarowa.pl

Insights

Serum alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) activity is elevated in intrahepatic cholestasis of pregnancy (ICP). This finding offers a new biochemical marker for assessing ICP severity during pregnancy.

Area of Science:

  • Hepatology
  • Obstetrics
  • Biochemistry

Background:

  • Intrahepatic cholestasis of pregnancy (ICP) poses risks to perinatal health.
  • Alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) is a cytoplasmic enzyme found in serum.

Purpose of the Study:

  • To investigate the characteristics of alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) activity in pregnant women with ICP.

Main Methods:

  • 100 women in their third trimester were studied: 58 with ICP and 42 healthy controls.
  • A group of 26 nonpregnant women was included for comparison.
  • Assessed serum levels of alpha-HBDH, bilirubin fractions, bile acids, alkaline phosphatase, liver enzymes, lipids, and total protein.

Main Results:

  • Serum alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) activity was significantly increased in the third trimester of ICP pregnancies.
  • Elevated alpha-HBDH activity showed a positive correlation with total and direct bilirubin levels and total alkaline phosphatase activity.

Conclusions:

  • Serum alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) activity is a valuable biochemical marker for evaluating the severity of intrahepatic cholestasis of pregnancy (ICP).
Abstract